$135.27
0.23% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US4523271090
Symbol
ILMN

Illumina Stock price

$135.27
-9.09 6.30% 1M
+28.81 27.06% 6M
-0.39 0.29% YTD
-3.60 2.59% 1Y
-239.50 63.91% 3Y
-188.48 58.22% 5Y
-49.39 26.75% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.31 0.23%
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Key metrics

Market capitalization $21.45b
Enterprise Value $23.19b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 42.47
EV/Sales (TTM) EV/Sales 5.28
P/S ratio (TTM) P/S ratio 4.89
P/B ratio (TTM) P/B ratio 10.06
Revenue growth (TTM) Revenue growth -1.68%
Revenue (TTM) Revenue $4.39b
EBIT (operating result TTM) EBIT $974.00m
Free Cash Flow (TTM) Free Cash Flow $546.00m
Cash position $939.00m
EPS (TTM) EPS $-10.00
P/E forward negative
P/S forward 4.97
EV/Sales forward 5.37
Short interest 5.14%
Show more

Create a Free Account to create an Illumina alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Illumina Stock Analysis

Analyst Opinions

27 Analysts have issued a Illumina forecast:

13x Buy
48%
13x Hold
48%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Illumina forecast:

Buy
48%
Hold
48%
Sell
4%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
4,390 4,390
2% 2%
100%
- Direct Costs 1,582 1,582
8% 8%
36%
2,808 2,808
2% 2%
64%
- Selling and Administrative Expenses 200 200
81% 81%
5%
- Research and Development Expense 1,244 1,244
8% 8%
28%
1,364 1,364
307% 307%
31%
- Depreciation and Amortization 390 390
9% 9%
9%
EBIT (Operating Income) EBIT 974 974
1,147% 1,147%
22%
Net Profit -1,585 -1,585
41% 41%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
Business Wire
12 days ago
PORTLAND, Maine--(BUSINESS WIRE)--Ovation.io, Inc., an organization dedicated to building best in class multi-omics datasets, today announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, that will work to accelerate advancements in precision medicine. The collaboration will address challenges in drug development by harnessin...
Positive
Seeking Alpha
24 days ago
The S&P is up 27% in 2024, including a 5.5% rally in November. The Euphoria index is at record highs, indicating investor sentiment is extremely bullish. While 2025 is likely to see much larger volatility, there are still many excellent blue-chip opportunities to buy for a potentially significant 2025. Here are 11 Ultra Sleep Well At Night quality companies that are 45% undervalued, growing at ...
Neutral
PRNewsWire
24 days ago
SAN DIEGO , Dec. 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2024 Presentation at 9:00am Pacific Time (12:00pm Eastern Time) immediately followed by a Q&A Session to begin at approximately 9:20am Pacific Time (12:20pm Eastern Time) The...
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 12,010
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today